Please check your internet connection and try again.
# Megacv Duo
## Overview
Megacv Duo is a fixed-dose combination antibiotic containing **Amoxicillin trihydrate** (a beta-lactam) and **Potassium Clavulanate** (a beta-lactamase inhibitor). The clavulanate component extends the spectrum of amoxicillin to include beta-lactamase-producing organisms.
## Primary Indications
* Community-acquired pneumonia
* Acute bacterial sinusitis
* Acute otitis media
* Skin and skin structure infections
* Urinary tract infections (UTIs)
* Dental infections
## Adult Dosing
* **Mild to Moderate Infections:** 500 mg/125 mg orally every 8 or 12 hours.
* **Severe Infections/Respiratory Tract:** 875 mg/125 mg orally every 12 hours.
* *Note: High-dose formulations (e.g., 2000 mg/125 mg extended-release) are sometimes used for resistant Streptococcus pneumoniae; follow local antibiogram protocols.*
## Pediatric Dosing
* **General Rule:** Dosages are calculated based on the **amoxicillin** component.
* **Typical Dose:** 25 mg/kg/day to 45 mg/kg/day divided every 12 hours.
* **Severe Infections (e.g., Otitis Media):** 80–90 mg/kg/day divided every 12 hours.
* *Caution:* Do not use the 875 mg tablet in children weighing < 40 kg due to the fixed ratio of clavulanate, which may cause GI distress or exceed recommended daily limits.
## Dose Adjustments
* **Renal Impairment:** Requires dose reduction or extended intervals if CrCl < 30 mL/min. Do not use extended-release formulations in severe renal impairment (CrCl < 30 mL/min).
* **Hepatic Impairment:** Use with caution; monitor hepatic function periodically.
## Contraindications
* History of serious hypersensitivity reactions (anaphylaxis) to any penicillin.
* History of cholestatic jaundice or hepatic dysfunction associated with previous use of amoxicillin/clavulanate.
## Adverse Effects
* **Common:** Diarrhea (frequently associated with clavulanate), nausea, vomiting, abdominal pain, skin rash (non-allergic maculopapular rash).
* **Serious:** *Clostridioides difficile*-associated diarrhea (CDAD), severe hypersensitivity (anaphylaxis), drug-induced hepatitis/cholestatic jaundice.
## Key Drug Interactions
* **Methotrexate:** Amoxicillin may decrease the renal excretion of methotrexate, increasing risk of toxicity.
* **Warfarin:** May increase INR and risk of bleeding; monitor PT/INR closely.
* **Oral Contraceptives:** May decrease the efficacy of hormonal birth control (use barrier method).
* **Probenecid:** Decreases renal excretion of amoxicillin, increasing serum levels.
## Monitoring
* **Hepatic:** Monitor liver enzymes (ALT/AST) and bilirubin if therapy exceeds 14 days or if symptoms of hepatic injury develop (jaundice, dark urine).
* **Renal:** Monitor BUN/Creatinine in patients with pre-existing renal dysfunction.
* **Allergic:** Monitor for signs of rash, angioedema, or anaphylaxis.
## Clinical Pearls
* **Administration:** Take with food or a meal to minimize gastrointestinal upset.
* **Allergy:** Distinguish between true IgE-mediated anaphylaxis (e.g., hives, swelling, wheezing) and non-allergic amoxicillin-induced rash (often seen in viral infections like EBV).
* **Ratios:** Ensure the formulation ratio matches the intended dose; high-dose amoxicillin formulations (e.g., 875mg) contain the same amount of clavulanate (125mg) as lower-dose versions. Exceeding recommended clavulanate daily limits increases the risk of hepatotoxicity.
***Disclaimer:** This information is for educational purposes only. Always verify current prescribing information, local infectious disease guidelines, and patient-specific contraindications via official pharmaceutical resources or institutional pharmacy bulletins before prescribing.*
